FDA flagged BPC-157 and roughly 19 other peptides for further evaluation, pausing compounding. Reclassification toward Category 1
This helps allow the skin to heal and recover and reduces the risk of side effects
There are currently over 22,260 active clinical trials recruiting participants
Intended for scientific investigation and specialized peptide-focused research applications
This result is consistent with those of previous reports, supporting the notion that the TAD2 region plays a substantial role in the interaction with FOXO4 FHD 38
That is the evidence gap, stated plainly: the mechanism is well-motivated and the preclinical signal is consistent, but no human study has confirmed that any of it translates to people, at any dose, by any route